Kailera Therapeutics, Inc. (KLRA)
Latest KLRA Insider Trades
About Kailera Therapeutics, Inc. (KLRA)
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
- WALTHAM, MA
- 2026
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 175,000 | |
| Option exercise | 2 | 76,188 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
KLRA Insider Transactions (Form 4)
4719 Form 4 filings on record, the earliest from Apr 20, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kathleen Tregoning - Officer | Grant or award | Stock Option (right to buy) | 175,000 |
Recent KLRA Form 8-K Filings
3KLRA Insider Trading - FAQ
What is the latest insider trade for KLRA?
Kailera Therapeutics, Inc. (KLRA) had 2 insider filings in the last 90 days, with the most recent on 2026-07-08. The full record for KLRA runs to 19 Form 4 filings, the earliest from 2026-04-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying KLRA stock?
No insider purchases of KLRA were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling KLRA stock?
No insider sales of KLRA were filed in the last 90 days.
Where can I see KLRA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks KLRA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow KLRA insider buys?
Create a free InsiderAlpha account and press Watch on this page to add KLRA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Kathleen Tregoning view on EDGAR
- - Ronald C. Renaud Jr. view on EDGAR
- - RTW INVESTMENTS, LP view on EDGAR
- - Jiangsu Hengrui Pharmaceuticals Co., Ltd. view on EDGAR
- - BAIN CAPITAL INVESTORS LLC view on EDGAR
- - Adam Koppel view on EDGAR
- - Bain Capital Life Sciences Investors, LLC view on EDGAR
- - Andrew T. Kaplan view on EDGAR
- - Paula Cloghessy view on EDGAR
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track KLRA insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
